Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non–small cell lung cancer previously treated with crizotinib: Results from ASCEND-6

Yi‐Long Wu, Yuankai Shi, Daniel S.W. Tan, Liu Xiaoqing, Ying Cheng, Jianying Zhou, T. An, You Lü, Bo Zhu, Chunxue Bai, Vanessa Q. Passos, Yvonne Lau, Xun Liao, Li Zhang